|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.96 USD | +0.74% |
|
-.--% | - |
| Market Cap | 8.19B 7.14B 6.58B 6.19B 11.58B 772B 11.66B 78.28B 30.4B 380B 30.75B 30.09B 1,319B | P/E 2022 |
-13.6x | P/E 2023 | -15.9x |
|---|---|---|---|---|---|
| Enterprise Value | 7.5B 6.53B 6.02B 5.66B 10.59B 706B 10.67B 71.63B 27.82B 348B 28.14B 27.53B 1,207B | EV / Sales 2022 |
-
| EV / Sales 2023 | - |
| Free-Float |
93.64% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +0.74% |
| 3 years | 19.59 |  | 44.99 |
| 5 years | 12.01 | | 46.16 |
| 10 years | 9 | | 46.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Reents
PSD | President | 59 | 01/08/2024 |
John Renger
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/05/2019 |
Matthew Calistri
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Deborah Baron
BRD | Director/Board Member | 57 | 20/01/2021 |
Scott Reents
BRD | Director/Board Member | 59 | 01/08/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/08/24 | Issuer sale | Chief Medical Officer | 1,495,399 | 0.8208% | ||
| 01/08/24 | Bain Capital Private Equity LP
| Issuer sale | Company | 65,679,781 | 36.0492% | |
| 01/08/24 | Issuer sale | Executive/Senior Manager | 222,723 | 0.1222% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.74% | -.--% | -.--% | +32.20% | 8.19B | |
| -2.23% | -1.65% | +61.34% | +111.83% | 56.24B | |
| +4.60% | +5.85% | +54.47% | +43.04% | 43.76B | |
| -1.01% | +1.90% | -12.60% | -17.00% | 23.32B | |
| -3.59% | -2.11% | -4.81% | +368.46% | 21.34B | |
| +3.22% | +3.77% | +19.92% | -35.05% | 15.75B | |
| -0.67% | +0.65% | +14.86% | -38.42% | 15.6B | |
| -1.26% | -3.12% | +27.22% | +173.65% | 13.18B | |
| +3.07% | +3.59% | +25.54% | - | 12.01B | |
| +4.95% | +7.51% | +123.21% | +249.05% | 11.87B | |
| Average | +0.76% | +3.38% | +30.91% | +98.64% | 22.13B | |
| Weighted average by Cap. | +0.43% | +3.41% | +36.66% | +95.56% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | - | - |
| Net income | -352M -306M -282M -266M -497M -33.13B -500M -3.36B -1.3B -16.33B -1.32B -1.29B -56.59B | -433M -377M -348M -327M -612M -40.79B -616M -4.14B -1.61B -20.1B -1.62B -1.59B -69.68B |
| Net Debt | -523M -456M -420M -395M -740M -49.31B -745M -5B -1.94B -24.3B -1.96B -1.92B -84.23B | -695M -606M -559M -525M -983M -65.54B -990M -6.65B -2.58B -32.3B -2.61B -2.55B -112B |
Employees
355
- Stock Market
- Stocks
- CERE Stock
Select your edition
All financial news and data tailored to specific country editions
